The key processes of skin aging are now being understood in sufficient detail that targeted prescription therapies for ...

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has announced that the first group of patients has been dosed in a ...

The firm believes the key differentiator of QTORIN rapamycin lies in its unique formulation, which is a topical anhydrous gel that is shelf stable and offers a high dose of drug. Wainwright ...